Jonathan Karn

16PUBLICATIONS
57CO-AUTHORS
Major global burdens of diseaseInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 05, 2026
Reduction of the HIV-1 reservoir in T cells from people with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells.

Mary Ann Checkley, Benjamin G Luttge, Cheryl M Cameron

|Jan 15, 2026
Longitudinal T-Cell Phenotypic Dynamics During Sustained Antiretroviral Therapy in People With HIV.

Christophe Vanpouille, Alan Wells, Victor DeGruttola

|Dec 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.

Michael L Freeman, Brian M Clagett, Konstantin Leskov

|Oct 08, 2025
Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity.

Anthonia E Osuagwu, Michael Payne, Jürgen Bosch

|Sep 27, 2025
HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency.

Leah M Plasek Hegde, Lalith S Gunawardane, Farshad Niazi

|May 14, 2024
Direct Analysis of HIV mRNA m<sup>6</sup>A Methylation by Nanopore Sequencing.

Ethan Honeycutt, Fredrick Kizito, Jonathan Karn

Pageof 3

Frequent Collaborators

5 joint publications

Konstantin Leskov

3 joint publications

Kien Nguyen

3 joint publications

Uri Mbonye

3 joint publications

Benjamin Luttge